|
1
|
Laursen L: A preventable cancer. Nature.
516:(Suppl). S2–S3. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park YN: Update on precursor and early
lesions of hepatocellular carcinomas. Arch Pathol Lab Med.
135:704–715. 2011.PubMed/NCBI
|
|
3
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Worns MA and Galle PR: HCC
therapies-lessons learned. Nat Rev Gastroenterol Hepatol.
11:447–452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang JW, Jiang R, Deng L, Zhang X, Wang K
and Sun B: Circulation long non-coding RNAs act as biomarkers for
predicting tumorigenesis and metastasis in hepatocellular
carcinoma. Oncotarget. 6:4505–4515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bussemakers MJ, van Bokhoven A, Verhaegh
GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N and Isaacs
WB: DD3: A new prostate-specific gene, highly overexpressed in
prostate cancer. Cancer Res. 59:5975–5979. 1999.PubMed/NCBI
|
|
10
|
Guo XQ, Xia J and Deng K: Long non-coding
RNAs: Emerging players in gastric cancer. Tumor Biol.
35:10591–10600. 2014. View Article : Google Scholar
|
|
11
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar
carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q,
Wu JY, Qin J, Jin T and Xu JM: Long noncoding RNA AFAP1-AS1
indicates a poor prognosis of hepatocellular carcinoma and promotes
cell proliferation and invasion via upregulation of the RhoA/Rac2
signaling. Int J Oncol. 48:1590–1598. 2016.PubMed/NCBI
|
|
14
|
Wang X, Sun W, Shen W, Xia M, Chen C,
Xiang D, Ning B, Cui X, Li H, Li X, et al: Long non-coding RNA DILC
represses self-renewal of liver cancer stem cells via inhibiting
autocrine IL-6/STAT3 axis. J Hepatol. 64:1283–1294. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou J, Li M, Yu W, Li W, Wang J, Xiang X,
Li G, Pan X and Lei D: AB209630, a long non-coding RNA decreased
expression in hypopharyngeal squamous cell carcinoma, influences
proliferation, invasion, metastasis, and survival. Oncotarget.
7:14628–14638. 2016.PubMed/NCBI
|
|
16
|
He R, Yang L, Lin X, Chen X, Lin X, Wei F,
Liang X, Luo Y, Wu Y, Gan T, et al: MiR-30a-5p suppresses cell
growth and enhances apoptosis of hepatocellular carcinoma cells via
targeting AEG-1. Int J Clin Exp Pathol. 8:15632–15641.
2015.PubMed/NCBI
|
|
17
|
Eggert T, McGlynn KA, Duffy A, Manns MP,
Greten TF and Altekruse SF: Epidemiology of fibrolamellar
hepatocellular carcinoma in the USA, 2000–10. Gut. 62:1667–1668.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
El-Serag HB: Epidemiology of
hepatocellular carcinoma in USA. Hepatol Res. 37:(Suppl 2).
S88–S94. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
European Association For The Study Of The
Liver; European Organisation For Research And Treatment Of Cancer:
ASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abdo AA, Hassanain M, AlJumah A, Al Olayan
A, Sanai FM, Alsuhaibani HA, Abdulkareem H, Abdallah K, AlMuaikeel
M, Al Saghier M, et al: Saudi guidelines for the diagnosis and
management of hepatocellular carcinoma: Technical review and
practice guidelines. Ann Saudi Med. 32:174–199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
European Association for Study of Liver;
European Organisation for Research and Treatment of Cancer:
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. Eur J Cancer. 48:599–641. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chatterjee R and Mitra A: An overview of
effective therapies and recent advances in biomarkers for chronic
liver diseases and associated liver cancer. Int Immunopharmacol.
24:335–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma X, Hui H, Jin Y, Dong D, Liang X, Yang
X, Tan K, Dai Z, Cheng Z and Tian J: Enhanced immunotherapy of
SM5-1 in hepatocellular carcinoma by conjugating with gold
nanoparticles and its in vivo bioluminescence tomographic
evaluation. Biomaterials. 87:46–56. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jaganathan A, Murugan K, Panneerselvam C,
Madhiyazhagan P, Dinesh D, Vadivalagan C, Aziz AT, Chandramohan B,
Suresh U, Rajaganesh R, et al: Earthworm-mediated synthesis of
silver nanoparticles: A potent tool against hepatocellular
carcinoma, Plasmodium falciparum parasites and malaria mosquitoes.
Parasitol Int. 65:276–284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sanchez Y and Huarte M: Long non-coding
RNAs: Challenges for diagnosis and therapies. Nucleic Acid Ther.
23:15–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu X, Ravindranath L, Tran N, Petrovics G
and Srivastava S: Regulation of apoptosis by a prostate-specific
and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell
Biol. 25:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou JY, Li W, Jin T, Xiang X, Li M, Wang
J, Li G, Pan X and Lei D: Gene microarray analysis of lncRNA and
mRNA expression profiles in patients with hypopharyngeal squamous
cell carcinoma. Int J Clin Exp Med. 8:4862–4882. 2015.PubMed/NCBI
|
|
29
|
Spencer SL and Sorger PK: Measuring and
modeling apoptosis in single cells. Cell. 144:926–939. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du Y, Gong J, Tian X, Yan X, Guo T, Huang
M, Zhang B, Hu X, Liu H, Wang Y, et al: Japonicone A inhibits the
growth of non-small cell lung cancer cells via
mitochondria-mediated pathways. Tumor Biol. 36:7473–7482. 2015.
View Article : Google Scholar
|
